Pancreatic Neuroendocrine Tumors
635 articles
Canadian Study NeoPancONE Focuses on Biomarker Validation
Dr. Jennifer Knox is leading the NeoPancONE trial for a biomarker that indicates which patients will respond better to certain chemotherapy before surgery.
My Eight-Year Un-Celebration of Surviving Pancreatic Cancer
William Ramshaw shares his thoughts and advice for those in treatment, on reaching the eight-year pancreatic cancer survivor mark.
Early Detection Trial for People at Higher Risk of Pancreatic Cancer
Relatives of pancreatic cancer patients or people who carry certain mutations can participate in an early detection clinical trial.
Risk Factors and Symptoms of Pancreatic Cancer
In this webinar oncologist Dr. Shaalan Beg outlines pancreatic cancer risk factors and gastroenterologist Dr. Oscar Alvarez explains how he looks at symptoms.
Pancreatic Cancer, Diabetes, and Endocrine Health: What You Need to Know
If you are dealing with diabetes and pancreatic cancer, Dr. Afreen Shariff outlines why careful management is so important.
Let’s Win Pancreatic Cancer Introduces New Features to Help Patients
In a new press release, Let’s Win introduces new features to help patients, including a Trial Finder and a Doctor Finder.
Pancreatic Cancer Research Highlights from ASCO GI 2025
Read about the pancreatic cancer research highlights from the ASCO GI 2025 conference, where treatments and quality-of-life were discussed.
Let’s Win Pancreatic Cancer Launches Updated Spanish Platform
Let’s Win is proud to announce the launch of it’s updated Spanish platform, with all the new features of the updated English platform.
Immunotherapy to Enhance Standard Chemotherapy for Advanced Pancreatic Cancer
Researchers are testing an immunotherapy drug approved for other advanced cancers for effectiveness against pancreatic cancer.